161 – 170 of 177
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
(
- Contribution to journal › Article
-
Mark
Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens
(
- Contribution to journal › Article
-
Mark
DNA and cell cycle analysis as prognostic indicators in breast tumors revisited
(
- Contribution to journal › Article
- 2000
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
-
Mark
Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
- 1999
-
Mark
No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer
(
- Contribution to journal › Article
- 1998
-
Mark
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
(
- Contribution to journal › Article